On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.
More Latest News
March 4, 2019
The Department of Health has been made aware of an email sent to physicians from SurveyClub. Please click here for more information. Continue reading
February 20, 2019
Medical Marijuana Use Registry fields for qualifying condition (k) do not comply with statutory and rule requirements. Submit form to board within 14-days of certification date. Continue reading